Annovis Bio Inc.

About Annovis Bio Inc.

Annovis Bio is a pioneering company in neurodegenerative disease research, dedicated to developing transformative therapies for disorders such as Alzheimer's Disease (AD) and Parkinson's Disease (PD). Their goal is to create effective treatments that restore nerve cell function and improve cognitive and motor abilities in patients by enhancing the flow of information.

Products & Services

Alzheimer's Disease Therapies:Focused on creating treatments to restore cognitive functions in patients with Alzheimer's Disease.

Parkinson's Disease Therapies:Aimed at developing therapies to improve motor function and slow disease progression in Parkinson's Disease patients.

Other Neurodegenerative Disorder Therapies:Research extends to multiple neurodegenerative disorders beyond Alzheimer's and Parkinson's.

Specialties

Neurodegenerative Disease Research Alzheimer's Disease Therapies Parkinson's Disease Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 6000000 MR: - FA: approximately $6 million FAN: 6000000	D: 2025-10-15 FD: 2025-10-15	1 investors
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 6000000 MR: - FA: approximately $6 million FAN: 6000000	D: 2025-10-10 FD: 2025-10-10	-
3	RT: Public Offering T: - FT: Public Offering	A: 21000000 MR: - FA: 21 million FAN: 21000000	D: 2025-02-04 FD: 2025-02-04	1 investors
4	RT: Public Offering T: - FT: Public Offering	A: 21000000 MR: - FA: $21 million FAN: 21000000	D: 2025-02-03 FD: 2025-02-03	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2023-10-31 FD: 2023-10-31	1 investors
6	RT: Private Placement and ATM Offering T: - FT: Private Placement and ATM Offering	A: 8700000 MR: - FA: approximately $8.7 million FAN: 8700000	D: 2023-04-11 FD: 2023-04-11	1 investors

Registered Direct Offering Latest

2025-10-15

$6.0M

1 investor (Pro only)

Registered Direct Offering 2025-10-10

$6.0M

Public Offering 2025-02-04

$21.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Leslie Alexander

Founder

M

MARIA L. MACCECCHINI

Founder, President, CEO and Executive Board Member

C

CHENG FANG

Senior VP, Research and Development

M

MICHAEL CHRISTIE

Vice President, Process Chemistry

M

MELISSA GAINES

Senior VP, Clinical Operations

E

EVE DAMIANO

Senior VP, Regulatory Operations

View 31 more team members with Pro

Unlock Full Team Directory

Recent News

Annovis Bio Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised